MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Wang, Rui ^a,b   Wang, Hong Bin ^c   Hao, Chan Juan ^a,b   Cui, Yi ^a,b   Han, Xiao Chen ^d   Hu, Yi ^a,b   Li, Fei Feng ^c   Xia, Hong Fei ^a,b   Ma, Xu ^a,b  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d TANGSHAN PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 101; STATHMIN; STATHMIN1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; RNA TRANSLATION; STMN1 GENE; TUMOR GROWTH; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; HUMANS; MICRORNAS; NEOPLASM METASTASIS; STATHMIN; UP-REGULATION;

EID: 84867417664     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046173     Document Type: Article

References (37)

1. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
2. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
3. Zhao Y, Srivastava D, (2007) A developmental view of microRNA function. Trends Biochem Sci 32: 189-197.
4. O'Day E, Lal A, (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12: 201.
5. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, et al. (2009) miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4: e7181.
6. Peurala H, Greco D, Heikkinen T, Kaur S, Bartkova J, et al. (2011) MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer. PLoS One 6: e26122.
7. Moes M, Le Bechec A, Crespo I, Laurini C, Halavatyi A, et al. (2012) A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition. PLoS One 7: e35440.
8. Wang H, Tan G, Dong L, Cheng L, Li K, et al. (2012) Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer. PLoS One 7: e34210.
9. Nilsson S, Moller C, Jirstrom K, Lee A, Busch S, et al. (2012) Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration. PLoS One 7: e36051.
10. Rothe F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, et al. (2011) Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 6: e20980.
11. Smits M, Nilsson J, Mir SE, van der Stoop PM, Hulleman E, et al. (2010) miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1: 710-720.
12. Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, et al. (2011) MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21(waf1/cip1). Pharm Res.
13. Cui J, Eldredge JB, Xu Y, Puett D, (2011) MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone. PLoS One 6: e21730.
14. Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ, (2011) MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol 6: 671-678.
15. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, et al. (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46: 2295-2303.
16. Yan D, Ng WL, Zhang X, Wang P, Zhang Z, et al. (2010) Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 5: e11397.
17. Tanaka T, Haneda S, Imakawa K, Sakai S, Nagaoka K, (2009) A microRNA, miR-101a, controls mammary gland development by regulating cyclooxygenase-2 expression. Differentiation 77: 181-187.
18. Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, et al. (2012) Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PLoS One 7: e31904.
19. Kang W, Tong JH, Chan AW, Lung RW, Chau SL, et al. (2012) Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS One 7: e33919.
20. Hsieh SY, Huang SF, Yu MC, Yeh TS, Chen TC, et al. (2010) Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog 49: 476-487.
21. Cui Y, Han Z, Hu Y, Song G, Hao C, et al. (2012) MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J Cell Physiol 227: 772-783.
22. Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, et al. (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer 82: 142-150.
23. Bieche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, et al. (1998) Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 78: 701-709.
24. Brattsand G, (2000) Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 83: 311-318.
25. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, et al. (2009) MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315: 1439-1447.
26. Su H, Yang JR, Xu T, Huang J, Xu L, et al. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142.
27. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, et al. (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer.
28. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
29. Mistry SJ, Atweh GF, (2001) Stathmin inhibition enhances okadaic acid-induced mitotic arrest: a potential role for stathmin in mitotic exit. J Biol Chem 276: 31209-31215.
30. Mistry SJ, Atweh GF, (2006) Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer. Mol Cancer Ther 5: 3248-3257.
31. Rana S, Maples PB, Senzer N, Nemunaitis J, (2008) Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther 8: 1461-1470.
32. Mistry SJ, Li HC, Atweh GF, (1998) Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J 334 (Pt 1) (): 23-29.
33. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, et al. (2007) Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 46: 759-768.
34. Oishi Y, Nagasaki K, Miyata S, Matsuura M, Nishimura S, et al. (2007) Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer. J Hum Genet 52: 271-279.
35. Olsen PH, Ambros V, (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216: 671-680.
36. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
37. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.